
If $NVDA shareholders are looking to exit for a company which will disrupt oncology, like CUDA did for computing, then look into @NorthwestBio. research.quackmaster.io/p/hu…

Finance, Economics, International Business. Biotech Investor. Business partner.

If $NVDA shareholders are looking to exit for a company which will disrupt oncology, like CUDA did for computing, then look into @NorthwestBio. research.quackmaster.io/p/hu…

$NWBO feels like we are approaching a time long awaited.

$NWBO November 17th through December 17th is the most likely window for MHRA decision announcement. We are now in the calm before the storm. Bullish

🇺🇸❤️ BIG NEWS & A LITTLE EXTRA HOPE! 🙏 We’re headed back to London for Braelyn’s next DCVax treatment, but this trip feels different! This past week, I had the incredible opportunity to speak personally with @DrOz! He’s been discussing Braelyn’s case with the FDA, and we’re exploring possible pathways to bring her ongoing DCVax treatments HOME to America! Could Braelyn’s next treatment in MARCH actually happen right here in the USA?! 🇺🇸 Nothing is finalized, but some very important doors may be opening! Please watch, share, and keep praying! ❤️🙏 #DCvaxForBraelyn #BraelynsFight @DrOzCMS

🚨 TODAY, I submitted my public comment to the FDA regarding its proposed Rare Disease Framework. As the mother of a 19-year-old fighting an aggressive, deadly brain cancer, I have one urgent message: Patients don’t just need faster drug approvals. They need ACCESS to promising treatments while they’re still alive to benefit from them. My comment shares Braelyn’s extraordinary journey, the clinical evidence and long-term survivors associated with DCVax-L, and the enormous barriers American families face trying to access investigational treatments. I also outline Braelyn’s Bill, built around four fundamental patient rights: ❤️ The Right to Know ❤️ The Right to Preserve ❤️ The Right to Choose ❤️ The Right to Access My most urgent request is Braelyn’s Rule: Patients facing life-threatening diseases should be able to access investigational treatments through their physicians, with informed consent and manufacturer participation, without unnecessary regulatory obstacles. We should not have to fly across an ocean to access a promising cancer treatment developed right here in America. The FDA’s new framework must measure success not just by how quickly treatments are evaluated, but by whether patients can actually access them while there’s still time. I’m sharing my full four-page public comment because this fight is about far more than my daughter. It’s about every family who deserves the opportunity to fight for their loved one’s life. Please read and share. ❤️🙏 #BraelynsBill #DCVaxForBraelyn #RareDiseases


🚨🇺🇸 BRAELYN’S STORY JUST MADE FOX BUSINESS! 🇺🇸🚨 What an incredible moment for our family! Today on Varney & Co., Stuart Varney brought up Steve Moore’s recent Rasmussen Reports article about Braelyn and the barriers seriously ill Americans face in accessing promising experimental treatments! Steve shared Braelyn’s story and called out the FDA, saying it’s CRUEL to withhold promising investigational treatments from desperately ill patients. Varney agreed, arguing that patients facing terminal illnesses should have the freedom to accept the risks of experimental treatments without liability concerns preventing companies from providing them. Then Steve asked a powerful question: “Whatever happened to my body, my choice?” He also pointed out that President Trump supports Right to Try, yet significant barriers remain between patients and the treatments they desperately need. THIS is the conversation we’ve been fighting to bring into the national spotlight! Our 19-year-old daughter is attending college, and her latest MRI shows no evidence of cancer recurrence. Yet we still have to travel to ENGLAND for her ongoing DCVax-L treatments—developed right here in AMERICA! We are so incredibly grateful to Steve Moore and Stuart Varney for bringing attention to Braelyn’s story and, more importantly, to the countless patients who deserve a fighting chance. Patients facing life-threatening illnesses shouldn’t have to fight their own government for the opportunity to fight for their lives. PLEASE WATCH AND SHARE! ❤️🙏 @realDonaldTrump @DrOzCMS @SecKennedy #DCVaxForBraelyn #RightToTry #DCVax #BraelynsFight $NWBO

CHM Minutes from August 👀 $nwbo #nwbo #dcvax app.box.com/s/jv487awvqzzsrd…

Amanda, I’m so glad you got that moment. You, Braelyn and Ben made those seconds count. ❤️ I’m sure @POTUS @realDonaldTrump sees the opportunity: a real DCVax cancer moonshot, making the pursuit of cancer cures a defining part of his agenda. @DrOzCMS @SecKennedy @WhiteHouse @FDA, please grant DCVax-L a National Priority Voucher, extend the Plausible Mechanism Pathway to include it, and open compassionate access here in the United States. Let’s bring Braelyn’s treatment home. #DCVaxForBraelyn #DCVax 🙏🏻🙏🏻🙏🏻


Some are saying $NWBO is only worth $2, $3, $4 or $5 per share after MHRA approves #DCVax-L. But this is short-sighted for a dendritic cell vaccine technology platform that can treat all solid tumor cancers, both operable & inoperable & all blood cancers: investorshub.advfn.com/board…

HUGE!!! PR is slowly starting to trickle out to mainstream media. $NWBO DC-VAX-L this morning on @FoxNews @foxandfriends They are talking about NWBO technology. Specifically @ 1:38 mark @RoswellPark we own their licensing! LETS GOOOO $NWBO

$NWBO #DCVaxForBraelyn THE CANCER SUCCESS STORY MAINSTREAM MEDIA DOESN’T WANT TO TELL THE SILENCE IS THE STORY WHO’S GOING TO BREAK IT FIRST? SurVaxM: Misses its Phase IIb primary endpoint → TODAY Show. National exposure. Merck + Moderna: Phase III announcement without detailed efficacy data → media frenzy. Moderna more than DOUBLES in one day. DCVax: Statistically significant Phase III survival results. Peer reviewed. Favorable safety profile. Remarkable long term survivors, including patients alive 20+ years. DCVax-L has been used to treat approximately 600+ GBM patients. And Braelyn… after three months of DCVax treatment, her family reported an MRI showing no evidence of disease. → Virtually no mainstream exposure. PURE SILENCE. $NWBO Explain the disparity. A press release moves billions. Published survival data gets ignored. And GBM may only be the beginning. DCVax is being developed as a platform across solid tumors… DCVax-L for operable tumors and DCVax-Direct for inoperable tumors. Then there’s Dr. Oz: “The President sent me a note this week about a kid who had his (her) Glioblastoma cured apparently and I’ve been pursuing it. It looks like they’ve been able to figure it out.” THAT’S WHY JOURNALISTS SHOULD BE ASKING. Interview the scientists and survivors. Start here: Braelyn’s mom, Amanda: @HollensbeAmanda 11+ year GBM survivor Thomas: @ThomasOwenMcCa1 And @greta is already paying attention… using her platform to spotlight Braelyn’s story and help raise money for her upcoming DCVax treatments. Think about that. An American family is relying on donations to repeatedly travel thousands of miles to London to access a personalized cancer treatment developed through decades of research in America. Help Braelyn Continue Her Brain Cancer Treatment gofund.me/9fb2db3b6 You don’t have to believe in DCVax. INVESTIGATE IT. Read the science. Challenge the company. Challenge the critics. Follow the evidence wherever it leads. Because this isn’t ultimately about a stock trading for pennies. Nearly 250,000 people worldwide die from brain cancer Roughly 680 people every single day. They aren’t statistics. They are someone’s child. Someone’s parent. Someone’s entire world. And when you’re fighting cancer, time isn’t money. Time is life. If the science is real, investigate it. But silence is no longer an acceptable answer. Because the people fighting for one more day deserve more than silence. They deserve the truth. @HollensbeAmanda @ThomasOwenMcCa1 @kshaughnessy2 @greta @RobertKennedyJr @POTUS @EdgeCGroup @DrOz @laralogan @healthranger @andrewcaravello @peterjkostis @joerogan @ShawnRyan762 @NBCNews @Merck @spimacoaddwaeih @moderna_tx @TuckerCarlson @CNBC @CNN @FoxNews @nytimes @washingtonpost @Reuters @AP @Forbes @statnews @MHRAgovuk @PGATOUR @aljedai $MRNA $MRK #DCVax #GBM #Glioblastoma #Cancer $NWBO


$NWBO “We are honored to have been invited to give a keynote speech to this important UK-wide group of oncologists, we are looking forward to discussing the new era of cancer vaccines and personalized medicine, and unique capabilities of DC based therapies"

$NWBO For anyone interested that hasnt already seen it, I posted a reply letter that I received from the MHRA about a formal complaint that I sent them on the 1000th day of the DCVax-L assessment. The letter can be seen here: investorshub.advfn.com/board…